Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK.
Department of Clinical Neurology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Amyotroph Lateral Scler Frontotemporal Degener. 2021 Nov;22(7-8):579-582. doi: 10.1080/21678421.2020.1853172. Epub 2020 Dec 7.
Spinocerebellar ataxia type 2 (SCA2) and amyotrophic lateral sclerosis (ALS) share a common molecular basis: both are associated with CAG-repeat expansion of and TDP-43-positive neuronal cytoplasmic inclusions. To date, the two disorders are viewed as clinically distinct with ALS resulting from 30-33 CAG-repeats and SCA2 from >34 CAG-repeats. We describe a 67-year old with a 32 CAG-repeat expansion of who presented with simultaneous symptoms of ALS and SCA2. Our case demonstrates that the clinical dichotomy between SCA2 and -ALS is false. We suggest instead that CAG-repeat expansion length determines the timing of SCA2 clinical symptoms relative to onset of ALS; consistent with this age of onset of SCA2 but not -ALS, is dependent upon expansion length. Review of the literature and our local cohort provides evidence for occurrence of ALS in late stage SCA2, which may be under-recognised by clinicians who think of the two diseases as distinct.
脊髓小脑共济失调 2 型(SCA2)和肌萎缩侧索硬化症(ALS)具有共同的分子基础:两者都与 和 TDP-43 阳性神经元细胞质包含物的 CAG 重复扩展有关。迄今为止,这两种疾病被认为在临床上是不同的,ALS 是由 30-33 个 CAG 重复引起的,SCA2 是由 >34 个 CAG 重复引起的。我们描述了一位 67 岁的患者,其 携带 32 个 CAG 重复扩展,同时出现 ALS 和 SCA2 的症状。我们的病例表明,SCA2 和 -ALS 之间的临床二分法是错误的。我们建议,CAG 重复扩展长度决定了 SCA2 临床症状相对于 ALS 发病的时间;与 SCA2 但不是 -ALS 的发病年龄一致,这取决于扩展长度。对文献和我们当地队列的回顾提供了证据表明在晚期 SCA2 中发生 ALS,这可能被认为这两种疾病是不同的临床医生所忽视。